Our Phase II early esophageal cancer (EC) detection study ESCEND started, coordinated by Vasilis Ntziachristos. The study follows exciting results showing up to 40% improvement in early EC using fluorescence molecular aging.
Partners
 |
 |
 |
source: GUT BMJ
Our Phase II early esophageal cancer (EC) detection study ESCEND started, coordinated by Vasilis Ntziachristos. The study follows exciting results showing up to 40% improvement in early EC using fluorescence molecular aging.
|
|
|